The Canadian Cancer Trials Group
banner
cctg.bsky.social
The Canadian Cancer Trials Group
@cctg.bsky.social
The Canadian Cancer Trials Group (CCTG) is an academic cooperative oncology group that designs and conducts clinical trials testing cancer therapy, supportive care and prevention interventions across Canada.
Today is #WorldCancerDay and #CCTG supports our 2,100 network researchers across Canada conducting the #ClinicalTrials that have a direct impact on improving treatment option for cancer patients @WorldCancerDay #CancerResearch
February 4, 2026 at 4:59 PM
Apply now for the #CCTG #VISION leadership mentoring and training program, providing investigators the opportunity to enhance their leadership skills through interactive, expert-facilitated workshops. Find out how to apply > buff.ly/qEhoFIW
January 21, 2026 at 12:30 PM
January is Cervical Cancer Awareness Month - A reminder cervical cancer is preventable and why regular screening is so important, combined with HPV vaccination, cervical cancer is one of the most preventable cancers in Canada. #CervicalCancerAwarenessMonth.
January 20, 2026 at 12:30 PM
The results of the BR.31 global phase III study, testing adjuvant durvalumab in patients with completely resected non–small cell lung cancer and led by #CCTG, were published in the Journal of Clinical Oncology. buff.ly/JDYY7h2
January 16, 2026 at 6:00 PM
Applications are now being accepted for the #CCTG 2026-2027 New Investigator Cancer Trials Practicum - a training program that enables the best and brightest new Canadian oncology researchers to acquire training and experience in cancer clinical trial conduct. Find how to apply: buff.ly/pVU9ts3
January 5, 2026 at 1:01 PM
Mark your Calendars! #CCTG is pleased to announce that the 2026 Annual Spring Meeting of Participants will be held April 24-26, 2026, at the Chelsea Hotel in Toronto. buff.ly/i4nddE9
December 18, 2025 at 12:02 PM
The @theNCI #MyeloMATCH precision medicine trial for #AML or #MDS has some initial results that are being presented in an oral presentation and 5 posters at the #ASH25 meeting this weekend! Find out more here > buff.ly/6HaGwyz

@SWOG
@eaonc
@ALLIANCE_org
#NCORP
December 5, 2025 at 7:45 PM
The holiday season is upon us - here is a reminder of all the specific dates and closures that will effect #CCTG specimen collection and delivery. This applies to all centres who are participating in #CCTG led trials. buff.ly/aUuXQzq
December 1, 2025 at 1:03 PM
The #CCTG Scientific Leadership selection task force have recently announced two new Frances Shepherd Award recipients, congratulations to Florencia Comelles and Claire Norman! Their recent CCTG research projects demonstrated excellence in clinical trial and translational research buff.ly/ISOepb4
November 26, 2025 at 12:01 PM
Its #NeuroendocrineCancer awareness month - lets take a closer look at the NE1 neuroendocrine cancer trial comparing re-treatment of Peptide Receptor Radionuclide Therapy in patients with metastatic metastatic gastroenteropancreatic #neuroendocrine tumours. #LetsTalkAboutNETs buff.ly/OfOSlzN
November 24, 2025 at 12:01 PM
Today is #WorldPancreaticCancerDay - We encourage everyone to help raise awareness, educate yourself about risk factors, and fund the research needed for new treatments. #WPCD #ItsAboutTime
November 20, 2025 at 12:02 PM
Reminder that this Friday (Nov 14th) we #YGK welcome Dr Désy as our special guest speaker discussing Soul Healing: Practicing Medicine in Rural Northern Communities and Building
Understanding within Care Providers - space is still available - Find out more here: buff.ly/CfRbmSE
November 12, 2025 at 12:12 PM
#RemembranceDay - Today we remember and pay tribute to the Canadian armed forces members who have died in the line of duty. #CCTG honours everyone who continues to serve and who defend our values and freedoms. #LestWeForget
November 11, 2025 at 3:45 PM
November is #Neuroendocrine (#NET) Cancer Awareness Month. Today CCTG supports World #NETCancerDay to raise awareness for this often-misdiagnosed cancer. Trials like NE2 (STOPNET) are looking to improve outcomes for these patients #LetsTalkAboutNETs buff.ly/mE3LstH
November 10, 2025 at 1:02 PM
The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S
November 6, 2025 at 1:01 PM
#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ
November 5, 2025 at 1:01 PM
November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M
November 4, 2025 at 12:30 PM
#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...
October 31, 2025 at 11:32 AM
A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years.
buff.ly/CfRbmSE
October 24, 2025 at 3:11 PM
Results from the primary analysis of the ctDNA-negative cohort from the international DYNAMIC-III (CO29) colon cancer clinical trial were presented at the #ESMO25 Presidential Symposium and simultaneously published in #NatureMagazine. @agitg @petermaccc @ccsresearch @cancersociety buff.ly/YeYWTde
October 20, 2025 at 5:34 PM
Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.
October 20, 2025 at 3:25 PM
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...
October 20, 2025 at 12:47 PM
The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y
October 10, 2025 at 12:03 PM
#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI
October 9, 2025 at 12:15 PM
The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > buff.ly/MZzXJI1 buff.ly/MZzXJI1
October 8, 2025 at 12:02 PM